DOTTIKON EXCLUSIVE SYNTHESIS AG manufactures high-quality performance chemicals, intermediates, and exclusive active pharmaceutical ingredients (APIs) for the world's leading chemical, biotech, and pharmaceutical industry.
The company with its production site in Dottikon (Aargau, Switzerland) is specialized in hazardous reactions and positions itself as strategic development and manufacturing partner and performance leader. Its safety culture created over the past 105 years guides the innovative use of hazardous reactions, low-temperature and high-pressure chemistry, as well as continuous processing in order to challenge, tighten, or shorten conventional chemical synthesis routes, improve selectivities, yields, and purities, and reduce waste.
Hembrunnstrasse 17, 5605 Dottikon – Switzerland
|Date||Trading entity / Person||Association||Trade type||Volume|
|24.07.23||None||Executive member||Sell||CHF 72,600.00|
|15.06.23||None||Executive member||Sell||CHF 85,872,280.00|
|15.06.23||None||Non-Executive member||Buy||CHF 26,000.00|
|01.06.23||None||Non-Executive member||Buy||CHF 30,240.00|
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.